David A. Khan, MD
Program Director, Allergy & Immunology Fellowship Program
Professor of Medicine
UT Southwestern Medical Center
Dallas, TX

Dr. David A. Khan is Professor of Internal Medicine & Pediatrics at the University of Texas Southwestern Medical Center in Dallas. He is the Training Program Director for the Allergy & Immunology fellowship program at Southwestern. Dr. Khan is a Past President of the Texas Allergy, Asthma and Immunology Society and is a member of the Joint Task Force on Practice Parameters for Allergy & Immunology. Dr. Khan received his medical degree from the University of Illinois. After completing an Internal Medicine residency at the Good Samaritan Medical Center in Phoenix, Arizona he went on to fellowship training in Allergy & Immunology at the Mayo Clinic. His research interests include drug allergy, mood disorders in asthma, rush immunotherapy, and treatment of refractory chronic urticaria.

Anita L. Nelson, MD
Professor Emeritus, Obstetrics and Gynecology
David Geffen School of Medicine at UCLA
Clinical Professor Obstetrics and Gynecology
University Southern California
Professor and Chair of Obstetrics and Gynecology
Western University of Health Sciences
Torrance, CA

Dr. Anita L. Nelson is a Professor Emeritus in the Department of OB-GYN at the David Geffen School of Medicine at UCLA, voluntary Clinical Professor of OB-GYN at USC School of Medicine and Professor and Chair of the Department of OB-GYN at Western University Health Sciences. She is also Medical Director of Research for Essential Access Health which conducts clinical trials for the NIH, Gates Foundation and commercial entities. She worked at Harbor-UCLA for 30 years as Chief of Women’s Healthcare Programs, where she was Medical Director for over two decades the largest women’s nurse practitioner education program in the country. Her areas of interest are contraception, menopause, infection, and menstrual disorders. She has participated in more than $60 million dollars of funded research and has authored over 200 articles for professional journals. Anita is a senior author of Contraceptive Technology, is a member of the editorial boards of Contraception, Contraceptive Technology Update, Contraception and Reproductive Medicine, Journal of Women’s Health, and AJOG, and is a reviewer for many other journals.

Jay H. Shubrook, DO, FAAFP, FACOFP
Professor, Primary Care Department
Director of Clinical Research
Director of Diabetes Services
Touro University California
Vallejo, CA

Dr. Jay Shubrook is a Family Physician and Fellowship trained Diabetologist. He is currently a Professor at Touro University California. He also serves as the Director of Clinical Research and the Director of Diabetes Services. He has been doing diabetes work exclusively for 15 years. He is the Associate Editor for the JAOA and Clinical Diabetes. He is on the Editorial Advisory Board of the American Family Physician. He serves on the Global Advisory Board for Springer/Nature Diabetes website called Medicine Matters- Diabetes. He is the immediate past Chair of the Primary Care Advisory Board of the American Diabetes Association. He oversees a large Diabetes Prevention Program network. His research interests focus on early intervention for type 2 diabetes. His professional goals are to better train the primary care workforce to manage diabetes.

Karol E. Watson, MD, PhD, FACC
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women's Heart Health Program
David Geffen School of Medicine at UCLA
John Mazziotta, MD, PhD Term Chair in Medicine
Los Angeles, CA

Dr. Karol E. Watson is a Professor of Medicine/Cardiology and a board-certified, full-time cardiologist at the Geffen School of Medicine at UCLA. She holds the John C. Mazziotta Term Chair in Medicine and was honored to be named Cardiologist of the Year, by the California chapter of the American College of Cardiology (ACC) in 2017. Dr. Watson received her undergraduate degree from Stanford University, her Medical Degree from Harvard Medical School, magna cum laude, and her PhD in Physiology from UCLA. She completed a residency in Internal Medicine and a fellowship in Cardiology at UCLA and continued there as part of the UCLA Specialty Training and Academic Research program and as Chief Fellow in Cardiovascular Diseases at UCLA.

Currently, Dr. Watson is director of the UCLA Barbra Streisand Women’s Heart Health Program at UCLA, Co-Director of the UCLA Program in Preventative Cardiology, and director of the UCLA Fellowship Program in Cardiovascular Diseases.

Dr. Watson contributes nationally on a number of fronts as well. She is a Principal Investigator for several large NIH studies, and serves on several NIH Steering committees. She is currently chair of the Clinical Chemistry and Clinical Toxicology Devices Panel of the Food and Drug Administration. Dr. Watson is past Vice President for the Association of Black Cardiologists (ABC); and immediate past chairperson of the scientific advisory board for Womenheart, – the largest national organization for women living with heart disease. Dr. Watson has received many honors including “America’s Top Physicians” designation from Black Enterprise magazine, a Super Doctors designation from “Tu Ciudad” and “Los Angeles” magazines, and in 2010 she was awarded a “Red Dress Award” from Women’s Day magazine. Dr. Watson has been quoted in many papers, journals, and periodicals, including USA Today, the Los Angeles Times, Woman’s Day, and Redbook magazines. She has appeared in interviews on Lifetime television, NBC News, and PBS, among others. Also, Dr. Watson was one of the physician hosts of the TLC television series “Guardian Angels, MD,” as well as an advisor to, and featured in the Emmy award-winning PBS series “The Mysterious Human Heart.”

The American Society of Hypertension recognizes Dr. Watson as a Specialist in Hypertension, she chairs the Cholesterol committee of the Association of Black Cardiologists and serves on several committees and panels of the National Institutes of Health including serving on the NIH Expert Panel for the Integrated Clinical Guideline for Cardiovascular Risk Reduction. She is currently chairperson of the national advisory board for WomenHeart (a national organization dedicated to women with heart disease), a former member of the advisory board for the California Heart Disease and Stroke Prevention program, and Chairperson of the FDA Clinical Chemistry and Clinical Toxicology Devices Panel.

Dr. Watson’s more than 100 publications and presentations have addressed many subjects including prevention of heart disease, vascular calcification, hormone replacement therapy, the metabolic syndrome, hypertension, hypercholesterolemia, and. cardiovascular disease in African Americans.